The Blueprint Medicines Corp brand, founded in 2000 (United States), from 2951 sister brands and 17477 competing brands. Blueprint Medicines Corp is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. Blueprint Medicines Corp is part of the Drug Manufacturers activity sector.

Blueprint Medicines Corp is a brand of NOVARTIS N (NOVN) Share price

Share price and profitability of the share NOVARTIS N (Blueprint Medicines Corp)

Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 87.36

Portfolio valuation
NOVARTIS N (Blueprint Medicines Corp) over 5 years* CHF 99.43

Stock market history NOVARTIS N (Blueprint Medicines Corp)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more